|
Market Cap (2-Jul) $356,619,552 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (19-Jun) 27,150,697 (1.86%) (138th) |
|
52w High $0.415 |
52w Low $0.223 |
P/E 7.50 |
EPS -0.03 |
IMM released this announcement to the ASX on 6 January 2023, 16:13. The announcement is not marked as price sensitive, and is 4 page(s) in length and 21.66kb in size.
You can view all announcements from IMM and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMM was 0.610% short sold according to ASIC data. It was ranked the 282nd most shorted stock on the ASX. It is now ranked as the 138th most shorted stock on the ASX with 1.859% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IMM | |
|---|---|
| Application for quotation of securities - IMM | 29 June 2023, 10:09 |
| US patent granted for Efti with PD-1 pathway inhibitor | 27 June 2023, 14:37 |
| Immutep completes underwritten retail entitlement offer | 27 June 2023, 8:16 |
| Notification of cessation of securities - IMM | 6 January 2023, 16:13 |
| TACTI-003 trial 50% enrolment milestone has been achieved | 4 January 2023, 8:19 |
| Update on MBC trial design following successful FDA meeting | 23 December 2022, 13:00 |
| Change of Director's Interest Notice L Turnbull | 22 December 2022, 15:58 |
You must be logged in to post a reply.
